AR051632A1 - IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY - Google Patents
IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCYInfo
- Publication number
- AR051632A1 AR051632A1 ARP050103880A AR051632A1 AR 051632 A1 AR051632 A1 AR 051632A1 AR P050103880 A ARP050103880 A AR P050103880A AR 051632 A1 AR051632 A1 AR 051632A1
- Authority
- AR
- Argentina
- Prior art keywords
- iron
- heminic
- ionic
- prophylaxis
- treatment
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se relaciona con el campo de la salud publica y en particular con un preparado que contiene hierro ionico y hierro hemínico en forma de polvos para ser utilizado por vía oral en forma de tabletas o en suspension acuosa para l profilaxis y tratamiento de la deficiencia de hierro. El contenido de hierro ionico proviene de una sal ferrosa y el hierro hemínico de un hemoderivado en polvos que se obtiene a partir de sangre y otros productos naturales. El objetivo técnico de la presente está dirigido a un preparado de hierro ionico y hierro hemínico con efecto antianémico y reconstituyente, en forma estable, con elevadas propiedades biologicas debido a la presencia de aminoácidos, ácido ascorbico y ácido folico lo que confieren propiedades superiores a los productos a base de hierro ionico o hierro hemínico por separados determinando elevada absorcion y solubilidad del hierro total lo que permite al organismo humano elevar en corto tiempo la formacion de hemoglobina e incrementar el hierro sérico y sus reservas en forma de ferritina a la vez que estimula otras funciones biologicas del organismo. La esencia de la presente consiste en lograr un preparado de hierro ionico y hierro hemínico en forma de polvos para la profilaxis y tratamiento de la deficiencia de hierro que tiene en su composicion de 6 a 26% de Fumarato ferroso y de 74 a 94% de hemoderivado en polvos con una proporcion entre hierro ionico y hierro hemínico del 30 al 70% y un contenido de aminoácidos de 20 a 30 Ámol/100Ámol de proteínas. En suspension acuosa al 10% contiene una concentracion total de hierro entre 11 y 22 mg/mL. En tabletas con masa de 500 a 700mg contiene de 13 a 30 mg de hierro total, de 0,2 a 0,25 mg de ácido folico y de 45 a 55mg de ácido ascorbico. Además de su efecto en la profilaxis y tratamiento de l deficiencia de hierro pudiera ser empleado como reconstituyente en estados convalecientes y coadyuvantes en las terapias que provocan danos importantes por sus efectos secundarios, así como en patologías que cursan con estados hipercatabolicos.This is related to the field of public health and in particular to a preparation containing ionic iron and heminic iron in powder form to be used orally in the form of tablets or in aqueous suspension for prophylaxis and treatment of deficiency of iron. The ionic iron content comes from a ferrous salt and the heminic iron of a powdered blood product that is obtained from blood and other natural products. The technical objective of the present is directed to a preparation of ionic iron and heminic iron with antianemic and restorative effect, in a stable way, with high biological properties due to the presence of amino acids, ascorbic acid and folic acid which confer properties superior to products based on ionic iron or heminic iron separately, determining high absorption and solubility of total iron, which allows the human body to increase hemoglobin formation in a short time and increase serum iron and its ferritin-like reserves while stimulating other biological functions of the organism. The essence of this is to achieve a preparation of ionic iron and heminic iron in the form of powders for the prophylaxis and treatment of iron deficiency which has in its composition 6 to 26% ferrous fumarate and 74 to 94% of blood products in powders with a ratio between ionic iron and heminic iron of 30 to 70% and an amino acid content of 20 to 30 Amol / 100 Protein Amol. In 10% aqueous suspension contains a total iron concentration between 11 and 22 mg / mL. In tablets with a mass of 500 to 700mg it contains 13 to 30 mg of total iron, 0.2 to 0.25 mg of folic acid and 45 to 55mg of ascorbic acid. In addition to its effect on the prophylaxis and treatment of iron deficiency, it could be used as a restorative in convalescent and adjuvant states in therapies that cause significant damage due to its side effects, as well as in pathologies that occur with hypercatabolic states.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP050103880 AR051632A1 (en) | 2005-09-19 | 2005-09-19 | IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP050103880 AR051632A1 (en) | 2005-09-19 | 2005-09-19 | IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051632A1 true AR051632A1 (en) | 2007-01-31 |
Family
ID=37715900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103880 AR051632A1 (en) | 2005-09-19 | 2005-09-19 | IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR051632A1 (en) |
-
2005
- 2005-09-19 AR ARP050103880 patent/AR051632A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2790590T3 (en) | Pharmaceutical and nutritional products containing vitamin K2 | |
| IL186788A0 (en) | Nutritional supplement for hiv patients | |
| EA201070419A1 (en) | COMPOSITION FOR REGULATING METABOLISM OF LIPIDS | |
| WO2011003015A8 (en) | Nutritional supplement | |
| UA90893C2 (en) | Oral dosage forms of gemcitabine derivatives | |
| IL189104A (en) | Pharmaceutical preparation comprising balsalazide or balsalazide disodium for use in treating gastrointestinal disease | |
| RU2014135037A (en) | Nutritional supplements for people aged 50 years and over to increase vitality, immunity, eye and bone health | |
| Mettu et al. | Effect of casein phosphopeptide-amorphous calcium phosphate (cpp-acp) on caries-like lesions in terms of time and nano-hardness: An: in vitro: study | |
| RU2010151631A (en) | IRON BISGLYCINATE-CHELATE FOR USE IN ORAL TREATMENT OF ANEMIA IN PATIENTS WITH CELIACIA | |
| EA200900764A1 (en) | COMPOSITION FOR PREVENTION OF DENTAL DISEASES | |
| ES2354818T3 (en) | ORAL COMPOSITION THAT INCLUDES A FIRST COMPOSITION (A) AND A SECOND COMPOSITION (B) AS A COMBINATION PRODUCT FOR A SEPARATE AND EXTENDED USE IN TIME, IN THE HUMAN BODY COSMETIC TREATMENT. | |
| SV2007002213A (en) | IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY REF. 104/2005 | |
| AR051632A1 (en) | IONIC IRON AND HEMINIC IRON PREPARATION AND ITS VARIANTS IN THE PROPHYLAXIS AND TREATMENT OF IRON DEFICIENCY | |
| ES2795104T3 (en) | Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis | |
| MX2009001153A (en) | Novel edible aqueous aerosol foam. | |
| CN107362245A (en) | It is a kind of that there is the anti-oxidant and composition of reducing homosysteine | |
| CA2920942C (en) | Cocoa polyphenols and their use in the treatment or prevention of eosinophilic esophagitis | |
| CN108096429A (en) | A kind of mouth sprays for alleviating oral peculiar smell and preparation method thereof | |
| TW200626133A (en) | Oral medication for twice-daily administration | |
| Tamba et al. | Trace elements alleviate pain in mice and humans | |
| WO2009031922A1 (en) | Tablet for prophylaxis and treatment of dental and periodontium diseases | |
| Silva | Evaluation of the Effect of Sports Drinks and Tooth Bleaching in Tooth Enamel Microhardness | |
| JP2014185110A (en) | Cell activation drink and supplement | |
| PAVĂL et al. | RESEARCH ON THE VARIATION OF SOME BIVALENT CATIONS IN PATIENTS WITH DISEASES OF THE ORAL CAVITY. | |
| EP4312574A1 (en) | A stable, emulsion-forming liquid composition comprising amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |